BML Capital Management, an activist investor that owns 9.9% of Elevation’s shares, is urging the company to wind down ...

Alis Biosciences’ plan is a familiar tactic in the private equity world, but the firm will instead be listed on the public ...

Losing the FDA’s senior negotiators would slow the renewal of the user fee programs “considerably,” according to policy and ...

Industry representatives will still be allowed at these meetings, but they will no longer have a spot on the advisory ...

Like they say about the weather in Iceland, if you don’t like an action taken by the new administration, wait five minutes; ...

Eli Lilly’s shares shot up 11% pre-market on Thursday after orforglipron became the first small-molecule GLP-1 drug to ace a ...

With tariffs pushing manufacturing home to the U.S., Pitchbook warns of reduced M&A activity and venture capital funding.

Despite these cuts, the FDA should be able to stay above a "trigger" level that would prevent it from collecting fees from ...

Kennedy is planning modifications to the Vaccines Adverse Event Reporting System to identify whether vaccines contribute to ...

During the first quarter, 22 rounds of biopharma layoffs in California affected about 995 employees total, while 17 rounds in ...

GeoVax was using its HHS contract to develop its next-generation multi-antigen COVID-19 vaccine, which is in Phase IIb ...

Looking for a biopharma job in Massachusetts? Check out the BioSpace list of nine companies hiring life sciences ...